IQVIA to acquire drug discovery assets from Charles River Labs

IQVIA Holdings Inc. (NYSE:IQV), a $28 billion life sciences company based in Research Triangle Park, North Carolina, has announced it has entered into an agreement to acquire certain discovery services assets from Charles River Laboratories, as disclosed in a press release statement. The acquisition comes as IQVIA's stock trades at $164.88, significantly below its previous valuation, while the company generated $16.3 billion in revenue over the last twelve months. This strategic move represents IQVIA's continued expansion in the pharmaceutical services sector, allowing the company to enhance its capabilities in early-stage drug development and research services. By acquiring these assets from Charles River Laboratories, IQVIA strengthens its competitive position in the life sciences market and broadens its portfolio of offerings to biotechnology and pharmaceutical clients.